Watchdog accuses Pfizer of 'excessive' epilepsy drug price

The Competition and Markets Authority is investigating why the price of phenytoin sodium capsules to the NHS has risen by more than 25 times since 2012

CMA-screenshot.jpg
The CMA will consider any representations from Pfizer and Flynn Pharma before deciding if the law has been infringed

Pfizer has attracted damning criticism from the government's competition watchdog for allegedly charging “excessive” prices for its epilepsy tablets.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from News

Nick Kaye: ‘The NPA isn’t in any mood to back down’

 
• By 
 • comment

Chair of the National Pharmacy Association (NPA) Nick Kaye has said that he “definitely wouldn't be thinking about a U-turn” on collective action, amid “real anger” over a lack of April cash.

DH to place ‘explicit restrictions’ on funded blood pressure checks

  • comment

The pharmacy hypertension service specification is set to be updated to exclude patients who request “frequent measurement of their blood pressure”.

CPE hiring independent chair at £50k for 3-4 days a month

 
• By 
 • comment

CPE is recruiting a new independent chair to “provide strategic leadership” – the position pays £50k a year and only requires a “time commitment” of 3-4 working days per calendar month.

More from Business

Revealed: Which Morrisons pharmacy locations are closing?

 
• By 
 • comment

Four Morrisons pharmacies across England are set to close their doors for good, the supermarket has announced.

exclusive

Revealed: Pharmacy weight loss consultations rocket twenty-fold

 
• By 
 • comment

Consultation numbers for a pharmacy service provider’s weight management service have grown “exponentially” in the last year, C+D has learned.